Sihuan Pharmaceutical Holdings Group Ltd.;Xuanzhu Pharma Co., Ltd.
发明人:
申请号：
EP11732633.0
公开号：
EP2524917B1
申请日:
2011.01.17
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Fused pyridine derivatives shown as the general formula (I), and their pharmaceutically acceptable salts, stereoisomers or solvates thereof are disclosed, which belong to the technical field of medicines. The R 1 , R 2 , R 3 , Q, X and Y substituents in formula (I) are defined as in the description. Also disclosed are the preparation methods, pharmaceutical compositions comprising the compounds and uses of the compounds in the manufacture of the medicine for the treatment and/or prevention of noninsulin-dependent diabetes, hyperglycemia, hyperlipidemia and insulin resistance.
